Advanced genetic diagnostic solutions enabling precision medicine through comprehensive genomic insights for disease screening, carrier testing and pharmacogenomics.
Genedian is Genomix's comprehensive genetic testing platform that bridges the gap between advanced genomics and clinical practice. Using next-generation sequencing (NGS) and array-based technologies, Genedian delivers actionable genetic insights for disease prevention, carrier screening, and treatment optimization.
From hereditary disease risk assessment to pharmacogenomics profiling, Genedian empowers clinicians to make data-driven decisions that improve patient outcomes.
Next-generation sequencing delivers comprehensive variant detection across coding and non-coding genomic regions.
Comprehensive panels for BRCA, Lynch syndrome, hereditary cardiac conditions, and 200+ inherited disorders.
Optimize drug selection and dosing by analyzing patient genetic variants affecting drug metabolism and response.
Targeted cancer gene panels and tumor mutation profiling to guide precision oncology treatment decisions.
Expert-interpreted clinical reports with ACMG-compliant variant classification and actionable recommendations.
Access to certified genetic counselors to support clinicians and patients in understanding test results.
| Technology | Next-Generation Sequencing (NGS), Array CGH |
| Panel Coverage | 500+ disease-associated genes |
| Sample Types | Blood (EDTA), saliva, buccal swab, FFPE tissue |
| Turnaround Time | 7–14 working days |
| Report Format | Clinical PDF report + raw data (VCF/FASTQ) |
| Variant Classification | ACMG 5-tier classification |
| Accreditation | ISO 15189, CAP accredited laboratory |
| Languages | English, Thai |
| Data Security | PDPA compliant, encrypted data storage |